News

The designation applies to the use of Tamibarotene in patients with relapsed or refractory acute promyelocytic leukemia (APL) following treatment with all-trans retinoic acid (ATRA) and arsenic trioxide.

The drug, MK-0974, was generally well tolerated in the study. Responses specific to other measures, such as migraine-associated symptoms, functional disability and use of additional rescue medications also

The Lyon plant will replace Genzyme’s smaller plant in nearby Marcy l’Etoile and will provide more than twice the manufacturing capacity. Construction is expected to begin later this

Mucosal IgA antibodies are considered as a possible first line of defense against infection by HIV, according to Mymetics. The results demonstrated that more than 90% of non-human

Male hypogonadism is an increasingly recognized medical condition characterized by a reduced or absent secretion of testosterone from the testes. Reduced testosterone levels can lead to health problems

The randomized, double-blind study will compare the efficacy and safety of Labopharm’s once-daily formulation of trazodone to placebo in patients with major unipolar depressive disorder. The trial, which

The payment was triggered by completion of the licensing agreement following regulatory clearance from US authorities, the company said. The drug, ASA404 is a small-molecule vascular disrupting agent

The studies will now begin following the successful conclusion of a second phase II study and the outcome of discussions with the FDA and the European Medicines Agency.

The researchers’ findings suggest that GAB2 modifies an individual’s risk of developing Alzheimer’s disease when associated with other genes, including APOE4. The discovery, which was announced by researchers